| Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) T Bachelot, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 30 (5), 766-773, 2019 | 110 | 2019 |
| Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a … D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 32 (10), 1245-1255, 2021 | 51 | 2021 |
| The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. H Al-Shamsi, H Darr, I Abu-Gheida, J Ansari, MC McManus, H Jaafar, ... The Gulf journal of oncology 1 (32), 71-87, 2020 | 26 | 2020 |
| D7-02: Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR J Spicer, H Calvert, L Vidal, F Azribi, R Perrett, M Shahidi, G Temple, ... Journal of Thoracic Oncology 2 (8), S410, 2007 | 16 | 2007 |
| Extraosseous pericardial Ewing's sarcoma F Azribi, ARA Razak, G Bough, D Lee, D Rowe, N Bown, P Dildey, S Clark, ... Journal of Clinical Oncology 28 (4), e48-e50, 2010 | 9 | 2010 |
| Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study F Azribi, E Abdou, E Dawoud, M Ashour, A Kamal, M Al Sayed, I Burney BMC cancer 21, 1-8, 2021 | 8 | 2021 |
| Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy-case report and literature … J Ansari, YE Mohmmed, S Ghazal-Aswad, H Ansari, SMJ Akhter, ... Gynecologic Oncology Reports 38, 100878, 2021 | 4 | 2021 |
| General oncology care in libya A Attia, I Siala, F Azribi Cancer in the Arab world, 133-148, 2022 | 3 | 2022 |
| Imatinib in gastrointestinal stromal tumour: Northern Cancer Network experience F Azribi, ARA Razak, P Dildey, J Adam, J Wilsdon, M Verrill ecancermedicalscience 3, 2009 | 3 | 2009 |
| 143P Prevalence of BRCA1/2 mutations in patients with ovarian cancer in the Gulf region: The PREDICT study F Azribi, E Abdou, E Dawoud, M Ashour, A Kamal, M Alsayed, I Burney Annals of Oncology 31, S296-S297, 2020 | 1 | 2020 |
| BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region HO Alshamsi, A Alwbari, F Azribi, F Calaud, S Thuruthel, SH Tirmazy, ... Frontiers in Oncology 14, 1358982, 2024 | | 2024 |
| Oncocytic Carcinoma with Liver Metastasis: Unusual Treatment Strategies and Clinical Insights—A Case Report and Review of the Literature M Hourani, S Giridharan, F Azribi, H Ansari, J Ansari Case Reports in Oncological Medicine 2024 (1), 3039762, 2024 | | 2024 |
| Unilateral Axillary Lymphadenopathy in Cancer Patients Post-COVID-19 Vaccination: Review and Case Series SH Zoughbor, Z AlRasbi, A Yousif, M Al Ameri, MM Hussein, MS Hourani, ... Case Reports in Oncology 16 (1), 194-209, 2023 | | 2023 |
| Abstract P5-03-04: PIK3CA mutation prevalence in hormone receptor positive breast cancer patients in United Arab Emirates F Azribi, M Hourani, S Magdub, A Alawadhi, A Yousif, E Dawoud, ... Cancer Research 83 (5_Supplement), P5-03-04-P5-03-04, 2023 | | 2023 |
| Abstract P1-14-01: Incidence, Clinicopathological Features and Treatment Outcomes Of Young Breast Cancer Patients: A Cohort Analysis From a High-Volume Tertiary Cancer Center … A Al-Awadhi, M Hourani, M Hussein, F Alkindi, L Wahba, A AlAgha, ... Cancer Research 83 (5_Supplement), P1-14-01-P1-14-01, 2023 | | 2023 |
| Malignant Phyllodes tumor: A Multi-Tertiary Institutions retrospective analysis–United Arab Emirates (UAE) Experience N Balalaa, W Anam, M Hussein, F Azribi, E Dawoud, D Trad, N Bennini, ... European Journal of Surgical Oncology 49 (2), e66, 2023 | | 2023 |
| EP03. 01-010 Clinicopathological Characteristics of Non-Small Cell Lung Cancer patients in the United Arab Emirates and Correlation with Their Outcomes F Azribi, A Yousif, J Ansari, E Dawoud, D Trad, K Al Qawasmeh, ... Journal of Thoracic Oncology 17 (9), S241-S242, 2022 | | 2022 |
| Clinicopathologic characteristics and patient outcomes of malignant phyllodes tumors: A multi-institution experience. A Al-Awadhi, M Hussein, KH Al Qawasmeh, DA Trad, J Ansari, E Anwar, ... Journal of Clinical Oncology 40 (16_suppl), e23528-e23528, 2022 | | 2022 |
| The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Prior to Anti-Cancer Therapy H Al-Shamsi, F Azribi, I Abu-Gheida, H Jaafar, AA Razek Journal of Oncology Research Review & Reports. SRC/JONRR-137, 3, 2021 | | 2021 |
| 119P SURVIVAL ANALYSIS IN PATIENTS WITH MALIGNANT AIRWAY STENOSIS REFERRED FOR ENDOBRONCHIAL INTERVENTION AND SUBSEQUENT ANTI-CANCER TREATMENT V Dudzevicius, F Azribi, E Aynsley, R Sathyamurthy, A Bapusamy Lung Cancer, S52, 2013 | | 2013 |
Jawaher AnsariTawam Hospital在 seha.ae 的电子邮件经过验证
